Electrochemical immunosensor based on AuNPs/ERGO@CNT nanocomposites by one-step electrochemical co-reduction for sensitive detection of P-glycoprotein in serum

P-glycoprotein (P-gp), a transmembrane glycoprotein widely expressed on the surface of various cells, is highly associated with multidrug resistance (MDR) that heralds the malignant progress of disease after drug treatment. Notably, there have been reported that serum P-gp is a potential marker for...

Full description

Saved in:
Bibliographic Details
Published in:Biosensors & bioelectronics 2023-02, Vol.222, p.115001-115001, Article 115001
Main Authors: Lu, Tai-Cheng, Sun, Yi-Ming, Zhong, Yu, Lin, Xin-Hua, Lei, Yun, Liu, Ai-Lin
Format: Article
Language:English
Subjects:
ATP Binding Cassette Transporter, Subfamily B
ATP Binding Cassette Transporter, Subfamily B, Member 1
Biosensing Techniques - methods
Carbon nanotubes
Electrochemical immunosensor
Electrochemical Techniques - methods
Gold
Gold nanoparticles
Graphene oxide
Graphite
Immunoassay - methods
Limit of Detection
Metal Nanoparticles
Nanocomposites
P-glycoprotein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:P-glycoprotein (P-gp), a transmembrane glycoprotein widely expressed on the surface of various cells, is highly associated with multidrug resistance (MDR) that heralds the malignant progress of disease after drug treatment. Notably, there have been reported that serum P-gp is a potential marker for assessing the progression of disease resistance. Currently, there are few methods for point-of-care serum P-gp detection. In this study, we proposed a gold nanoparticles/electrochemically reduced graphene oxide@carbon nanotube (AuNPs/ERGO@CNT) modified immunosensor based on a one-step electrochemical co-reduction method. The limit of detection (LOD) of our constructed electrochemical immunosensor for P-gp detection reached 0.13 ng/mL, and the detection results in serum were consistent with ELISA. The developed immunosensor is expected to provide a scientific basis for the clinical application of serum P-gp monitoring and integrated medicine.
ISSN:0956-5663
1873-4235
DOI:10.1016/j.bios.2022.115001